Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Wayne D Hall a Office of Public
Policy and Ethics, Institute for Molecular Bioscience, University of
Queensland, Brisbane, Queensland 4072, Australia, b School of Public Health
and Community Medicine, University of New South Wales, Sydney, New
South Wales 2052, Australia, c School of Psychiatry,
University of New South Wales, Randwick, New South Wales 2031, Australia, d beyondblue: the national depression initiative,
Melbourne, Victoria 3122, Australia, e Drug Utilisation Subcommittee, Department of Health
and Ageing, Canberra 2601, Australia Correspondence to: A
Mant a.mant@unsw.edu.au
| |
Abstract |
|---|
Objective:
To examine the association between trends in antidepressant prescribing and suicide rates in Australia for 1991-2000.
Design:
Analysis of databases of suicide and rates of
antidepressant prescribing according to age and sex.
Setting:
Australian Bureau of Statistics data, sales data from the Australian pharmaceutical industry, prescribing data in
general practice.
Subjects:
Men and women aged 15 years and over in 10 year age groups.
Main outcome measures:
Trends in suicide rates and
trends in antidepressant prescribing. Association measured by
Spearman's rank correlations.
Results:
While overall national rates of suicide did not fall significantly, incidence decreased in older men and women and
increased in younger adults. In both men
(rs=
0.91; P<0.01) and women
(rs=
0.76; P<0.05) the higher
the exposure to antidepressants the larger the decline in rate of suicide.
Conclusions:
Changes in suicide rates and exposure to
antidepressants in Australia for 1991-2000 are significantly
associated. This effect is most apparent in older age groups, in which
rates of suicide decreased substantially in association with exposure
to antidepressants. The increase in antidepressant prescribing may be a
proxy marker for improved overall management of depression. If so,
increased prescribing of selective serotonin reuptake inhibitors in
general practice may have produced a quantifiable benefit in population
mental health.
|
What is already known on this topic
Previous studies have indicated an association between increased antidepressant prescribing and reduced suicide rate What this study adds
Most antidepressants are now prescribed by general practitioners The association may indicate the improved treatment of depression by general practitioners |
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
In many developed countries the number of prescriptions for antidepressants increased steeply during the 1990s, after the introduction of selective serotonin reuptake inhibitors (SSRIs).1-4 In some countries the increased rate of prescribing coincided with fall in the suicide rate.2-4
Research has been carried out to test the hypothesis that increased
antidepressant prescribing was partially responsible for this decline.
In Sweden between 1991 and 1996 antidepressant prescribing increased
steeply after the introduction of the SSRIs in 1990, and the rate of
suicides was inversely related to rates of antidepressant prescribing
in most age and sex groups.3 In another study in Sweden
Carlsten et al examined data for 1977-97 (using official mortality
statistics) and data on antidepressant use from surveys of sales to
pharmacies.2 They found that suicide rates declined over
the whole study period, but the rate of decline accelerated after the
SSRIs were introduced in 1990. In Hungary in 1984-98 antidepressant
prescribing rose steeply
Read all Rapid Responses